Standard

Endoglin Expression in Non-tumor and Tumor Cells of Different Origin. / Samoilovich, M. P.; Pinevich, A. A.; Vartanyan, N. L.; Smirnov, I. V.; Krutetskaya, I. Yu; Stolbovaya, A. Yu; Shashkova, O. A.; Gryazeva, I. V.; Berlina, M. A.; Smirnova, T. D.; Klimovich, V. B.

в: Cell and Tissue Biology, Том 12, № 6, 01.11.2018, стр. 437-447.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

Samoilovich, MP, Pinevich, AA, Vartanyan, NL, Smirnov, IV, Krutetskaya, IY, Stolbovaya, AY, Shashkova, OA, Gryazeva, IV, Berlina, MA, Smirnova, TD & Klimovich, VB 2018, 'Endoglin Expression in Non-tumor and Tumor Cells of Different Origin', Cell and Tissue Biology, Том. 12, № 6, стр. 437-447. https://doi.org/10.1134/S1990519X18060111

APA

Samoilovich, M. P., Pinevich, A. A., Vartanyan, N. L., Smirnov, I. V., Krutetskaya, I. Y., Stolbovaya, A. Y., Shashkova, O. A., Gryazeva, I. V., Berlina, M. A., Smirnova, T. D., & Klimovich, V. B. (2018). Endoglin Expression in Non-tumor and Tumor Cells of Different Origin. Cell and Tissue Biology, 12(6), 437-447. https://doi.org/10.1134/S1990519X18060111

Vancouver

Samoilovich MP, Pinevich AA, Vartanyan NL, Smirnov IV, Krutetskaya IY, Stolbovaya AY и пр. Endoglin Expression in Non-tumor and Tumor Cells of Different Origin. Cell and Tissue Biology. 2018 Нояб. 1;12(6):437-447. https://doi.org/10.1134/S1990519X18060111

Author

Samoilovich, M. P. ; Pinevich, A. A. ; Vartanyan, N. L. ; Smirnov, I. V. ; Krutetskaya, I. Yu ; Stolbovaya, A. Yu ; Shashkova, O. A. ; Gryazeva, I. V. ; Berlina, M. A. ; Smirnova, T. D. ; Klimovich, V. B. / Endoglin Expression in Non-tumor and Tumor Cells of Different Origin. в: Cell and Tissue Biology. 2018 ; Том 12, № 6. стр. 437-447.

BibTeX

@article{03b63a8b061e48df8ab458b15db33990,
title = "Endoglin Expression in Non-tumor and Tumor Cells of Different Origin",
abstract = "Abstract: The transmembrane protein endoglin (CD105) is a component of the receptor complex for TGF-β family growth factors. It is expressed primarily in endothelial cells, mesenchymal stromal cells, and early hematopoietic precursors. The density of CD105 on the membrane of endothelial cells increases upon their proliferation. A soluble endoglin form (sEng) is produced by a cleavage of an extracellular fragment from CD105, performed by the matrix metalloproteinase MMP-14. sEng blood level serves as an indicator of angiogenesis during the progression of some tumors. The contribution of tumor cells into the sEng pool remains unknown. We investigated the expression of CD105, production of sEng, as well as the mRNA level of two splice-variants of endoglin and mmp-14 genes using a collection of 43 cultures of tumorous and normal cells of different histological origin. Over half of the tumor cell lines and normal stromal cells contained cell populations expressing the membrane-bound endoglin. Cytoplasmic endoglin with unknown function was found in cells of three tumor lines. In all cell cultures, the mRNA expression of L-endoglin splice-variant prevailed over the expression of S-endoglin. We have investigated, for the first time, the formation of sEng in the stromal and tumor cells, and revealed the endothelial cells as the main source of sEng. Normal stromal cells and the majority of CD105+ tumor cells produce only low levels of sEng. Among the tumor cell lines, the highest sEng production was detected in the MeWo melanoma cells, that are characterized by the highest activity of mmp-14 gene.",
keywords = "CD105, cell lines, endoglin, endothelium, L-endoglin, mesenchymal stromal cells, mmp-14 gene, S-endo-glin, tumor cells",
author = "Samoilovich, {M. P.} and Pinevich, {A. A.} and Vartanyan, {N. L.} and Smirnov, {I. V.} and Krutetskaya, {I. Yu} and Stolbovaya, {A. Yu} and Shashkova, {O. A.} and Gryazeva, {I. V.} and Berlina, {M. A.} and Smirnova, {T. D.} and Klimovich, {V. B.}",
note = "Publisher Copyright: {\textcopyright} 2018, Pleiades Publishing, Ltd.",
year = "2018",
month = nov,
day = "1",
doi = "10.1134/S1990519X18060111",
language = "English",
volume = "12",
pages = "437--447",
journal = "Cell and Tissue Biology",
issn = "1990-519X",
publisher = "МАИК {"}Наука/Интерпериодика{"}",
number = "6",

}

RIS

TY - JOUR

T1 - Endoglin Expression in Non-tumor and Tumor Cells of Different Origin

AU - Samoilovich, M. P.

AU - Pinevich, A. A.

AU - Vartanyan, N. L.

AU - Smirnov, I. V.

AU - Krutetskaya, I. Yu

AU - Stolbovaya, A. Yu

AU - Shashkova, O. A.

AU - Gryazeva, I. V.

AU - Berlina, M. A.

AU - Smirnova, T. D.

AU - Klimovich, V. B.

N1 - Publisher Copyright: © 2018, Pleiades Publishing, Ltd.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Abstract: The transmembrane protein endoglin (CD105) is a component of the receptor complex for TGF-β family growth factors. It is expressed primarily in endothelial cells, mesenchymal stromal cells, and early hematopoietic precursors. The density of CD105 on the membrane of endothelial cells increases upon their proliferation. A soluble endoglin form (sEng) is produced by a cleavage of an extracellular fragment from CD105, performed by the matrix metalloproteinase MMP-14. sEng blood level serves as an indicator of angiogenesis during the progression of some tumors. The contribution of tumor cells into the sEng pool remains unknown. We investigated the expression of CD105, production of sEng, as well as the mRNA level of two splice-variants of endoglin and mmp-14 genes using a collection of 43 cultures of tumorous and normal cells of different histological origin. Over half of the tumor cell lines and normal stromal cells contained cell populations expressing the membrane-bound endoglin. Cytoplasmic endoglin with unknown function was found in cells of three tumor lines. In all cell cultures, the mRNA expression of L-endoglin splice-variant prevailed over the expression of S-endoglin. We have investigated, for the first time, the formation of sEng in the stromal and tumor cells, and revealed the endothelial cells as the main source of sEng. Normal stromal cells and the majority of CD105+ tumor cells produce only low levels of sEng. Among the tumor cell lines, the highest sEng production was detected in the MeWo melanoma cells, that are characterized by the highest activity of mmp-14 gene.

AB - Abstract: The transmembrane protein endoglin (CD105) is a component of the receptor complex for TGF-β family growth factors. It is expressed primarily in endothelial cells, mesenchymal stromal cells, and early hematopoietic precursors. The density of CD105 on the membrane of endothelial cells increases upon their proliferation. A soluble endoglin form (sEng) is produced by a cleavage of an extracellular fragment from CD105, performed by the matrix metalloproteinase MMP-14. sEng blood level serves as an indicator of angiogenesis during the progression of some tumors. The contribution of tumor cells into the sEng pool remains unknown. We investigated the expression of CD105, production of sEng, as well as the mRNA level of two splice-variants of endoglin and mmp-14 genes using a collection of 43 cultures of tumorous and normal cells of different histological origin. Over half of the tumor cell lines and normal stromal cells contained cell populations expressing the membrane-bound endoglin. Cytoplasmic endoglin with unknown function was found in cells of three tumor lines. In all cell cultures, the mRNA expression of L-endoglin splice-variant prevailed over the expression of S-endoglin. We have investigated, for the first time, the formation of sEng in the stromal and tumor cells, and revealed the endothelial cells as the main source of sEng. Normal stromal cells and the majority of CD105+ tumor cells produce only low levels of sEng. Among the tumor cell lines, the highest sEng production was detected in the MeWo melanoma cells, that are characterized by the highest activity of mmp-14 gene.

KW - CD105

KW - cell lines

KW - endoglin

KW - endothelium

KW - L-endoglin

KW - mesenchymal stromal cells

KW - mmp-14 gene

KW - S-endo-glin

KW - tumor cells

UR - http://www.scopus.com/inward/record.url?scp=85059343480&partnerID=8YFLogxK

U2 - 10.1134/S1990519X18060111

DO - 10.1134/S1990519X18060111

M3 - Article

AN - SCOPUS:85059343480

VL - 12

SP - 437

EP - 447

JO - Cell and Tissue Biology

JF - Cell and Tissue Biology

SN - 1990-519X

IS - 6

ER -

ID: 89780338